Division of Cardiology, Kyoto University Hospital
Kyoto, 606-8507, Japan
NCT Number: NCT01123291
The purpose of this study is to evaluate the long term clinical impact of routine follow-up coronary angiography after percutaneous coronary intervention (PCI). The primary endpoint is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at 3-year after percutaneous coronary intervention.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Phase 4
Kyoto, 606-8507, Japan
Routine follow-up coronary angiography after percutaneous coronary intervention has been performed to detect restenosis in a lot of PCI centers in Japan. On the other hand, previous studies reported that routine follow-up coronary angiography might lead to unnecessary reinterventions in asymptomatic patients. In this situation, the effect of routine follow-up coronary angiography on long-term clinical outcomes remains unknown. The purpose of this study is to evaluate the long-term clinical impact of routine follow-up coronary angiography after PCI compared with clinical follow-up alone. The primary endpoint of this study is a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure at three-year after percutaneous coronary intervention. The design of this study is almost all-comer design enrolling patients received PCI without any exclusion criteria.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
follow-up coronary angiography at 8-12 months after discharge for percutaneous coronary intervention
no routine follow-up coronary angiography at 8-12 months after discharge for percutaneous coronary intervention
Time frame: 4.8 years
a composite of death/myocardial infarction/stroke/emergency hospitalization for acute coronary syndrome/hospitalization for congestive heart failure
Time frame: 4.8 years
death
Time frame: 4.8 years
cardiac death
Time frame: 4.8 years
myocardial infarction
Time frame: 4.8 years
stent thrombosis defined bya Academic Reseach Consortium
Time frame: 4.8 years
both ischemic and hemorrhagic stroke excluding transient ischemic attach
Time frame: 4.8 years
bleeding complications defined by GUSTO and TIMI
Time frame: 4.8 years
any coronary revascularization
Time frame: 4.8 years
clinically-driven coronary revascularization
Time frame: 4.8 years
clinically-driven target-lesion revascularization
Time frame: 4.8 years
any target-lesion revascularization
Time frame: 4.8 years
coronary artery bypass grafting
Time frame: 4.8 years
angina
Time frame: 4.8 years
estimate-glomerular filtration rate
Time frame: 4.8 years
emergency hospitalization for acute coronary syndrome
Time frame: 4.8 years
hospitalization for congestive heart failure
Time frame: 4.8 years
composite of cardiac death, myocardial infarction or acute coronary syndrome
Time frame: 4.8 years
presence of follow-up coronary angiography
Time frame: 4.8 years
presence of clinically-driven follow-up coronary angiography
Takeshi Morimoto
Other
Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial
Acronym: ReACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details